Int J Mol Sci
March 2023
Leishmaniasis represents a complex of diseases with a broad clinical spectrum and epidemiological diversity, considered a major public health problem. Although there is treatment, there are still no vaccines for cutaneous leishmaniasis. Because spp.
View Article and Find Full Text PDFis a prevalent pathogen in hospital settings with increasing importance in infections associated with biofilm production. Due to a rapid increase in its drug resistance and the failure of commonly available antibiotics to treat infections, this bacterium has become a critical public health issue. For these multi-drug resistant , polymyxin antibiotics are considered the only option for the treatment of severe infections.
View Article and Find Full Text PDF